1. Home
  2. ELAB vs BDRX Comparison

ELAB vs BDRX Comparison

Compare ELAB & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elevai Labs Inc.

ELAB

Elevai Labs Inc.

HOLD

Current Price

$5.81

Market Cap

4.2M

Sector

N/A

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$2.42

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELAB
BDRX
Founded
2020
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.0M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ELAB
BDRX
Price
$5.81
$2.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
501.4K
2.8M
Earning Date
03-27-2026
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$285,948.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$2.22
52 Week High
$398.86
$92.00

Technical Indicators

Market Signals
Indicator
ELAB
BDRX
Relative Strength Index (RSI) 72.16 38.79
Support Level $1.25 $2.22
Resistance Level $9.59 $2.63
Average True Range (ATR) 0.76 0.40
MACD 0.46 -0.09
Stochastic Oscillator 55.22 3.77

Price Performance

Historical Comparison
ELAB
BDRX

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: